ALDER BIOPHARMACEUTICALS INC (ALDR) is a publicly traded company in the Unknown sector. Across all available filings, 29 corporate insiders have executed 363 transactions totaling $123.4M, demonstrating a bearish sentiment with -$87.7M in net insider flow. The most recent transaction on Oct 22, 2019 involved a purchase of 85,923,561 shares valued at $0.
No significant insider buying has been recorded for ALDR in the recent period.
No significant insider selling has been recorded for ALDR in the recent period.
Based on recent SEC filings, insider sentiment for ALDR is bearish with an Insider Alignment Score of 14/100 and a net flow of -$87.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ALDER BIOPHARMACEUTICALS INC (ALDR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 29 insiders are actively trading ALDR stock, having executed 363 transactions in the past 90 days. The most active insider is Rosen Fund IX L.p. Sevin (Executive), who has made 2 transactions totaling $42.7M.
Get notified when executives and directors at ALDR file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 22, 2019 | A. S. H. Lundbeck | Executive | Purchase | 85,923,561 | $N/A | $0 | |
| Oct 22, 2019 | Bruce Montgomery Alan | Executive | Tender | 9,628 | $18.00 | $173.3K | |
| Oct 22, 2019 | B. Siegall Clay | Executive | Tender | 31,714 | $18.00 | $570.9K | Large |
| Oct 22, 2019 | L. Yarno Wendy | Executive | Tender | 5,000 | $18.00 | $90.0K | |
| Oct 22, 2019 | T. L. Smith Jeffrey | Executive | Award | 16,230 | $N/A | $0 | |
| Oct 22, 2019 | T. L. Smith Jeffrey | Executive | Disposition | 21,502 | $18.00 | $387.0K | |
| Oct 22, 2019 | Hassler Randal | Executive | Award | 14,346 | $N/A | $0 | |
| Oct 22, 2019 | Hassler Randal | Executive | Disposition | 19,780 | $18.00 | $356.0K | |
| Oct 22, 2019 | B. Bucher James | Executive | Tender | 27,677 | $18.00 | $498.2K | |
| Oct 22, 2019 | B. Bucher James | Executive | Award | 15,619 | $N/A | $0 | |
| Oct 22, 2019 | Lavelle Erin | Executive | Tender | 16,092 | $18.00 | $289.7K | |
| Oct 22, 2019 | Lavelle Erin | Executive | Award | 11,684 | $N/A | $0 | |
| Oct 22, 2019 | Llc Redmile Group, | Executive | Tender | 8,244,896 | $N/A | $0 | |
| Oct 22, 2019 | Streck Paul | Executive | Disposition | 1,390 | $18.00 | $25.0K | |
| Oct 11, 2019 | B. Bucher James | Executive | Award | 904 | $9.20 | $8.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 163 | $105.5M | 71.4% |
Award(A) | 24 | $20.1M | 13.6% |
Purchase(P) | 11 | $17.8M | 12.1% |
Exercise(M) | 111 | $1.8M | 1.2% |
Tender(U) | 6 | $1.6M | 1.1% |
Disposition(D) | 4 | $834.6K | 0.6% |
Other(J) | 27 | $0 | 0.0% |
Conversion(C) | 17 | $0 | 0.0% |
Insider selling pressure at ALDER BIOPHARMACEUTICALS INC has increased, with 29 insiders executing 363 transactions across all time. Total sales of $105.5M significantly outpace purchases of $17.8M, resulting in a net outflow of $87.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.